Atara Biotherapeutics ATRA Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue$17.6MBeat by $15.8M
EPS$0.19Beat by $0.51
Revenue estimate$1.8M
EPS estimate-$0.32
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$550.0K
EPS estimate-$0.32
Versus estimates
Revenue
Diluted EPS
Ask the moment Atara Biotherapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Atara Biotherapeutics report Q2 2025 earnings?
- Atara Biotherapeutics (ATRA) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Atara Biotherapeutics's Q2 2025 revenue and EPS?
- Atara Biotherapeutics reported revenue of $17.6M and eps of $0.19 for Q2 2025.
- Did Atara Biotherapeutics beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $1.8M by $15.8M. EPS beat the consensus estimate of $-0.32 by $0.51.
- How did Atara Biotherapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 38.6% from $28.6M a year earlier.
- Where can I find Atara Biotherapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-106550) directly on SEC EDGAR. The filing index links above go to sec.gov.